![]() | |
Identifiers | |
---|---|
| |
CAS Number | |
PubChemCID | |
Chemical and physical data | |
Formula | C17H26N2O |
Molar mass | 274.408 g·mol−1 |
3D model (JSmol) | |
| |
|
5-Methoxy-N-propyl-N-isopropyltryptamine (5-MeO-PiPT) is asubstituted tryptamine derivative which is claimed to havepsychedelic effects. It acts as a 5-HT1A and 5-HT2A receptor agonist,[1] with an EC50 of 13.8 nM and an efficacy of 89% (vs 5-HT),[2] and has been sold as adesigner drug, first being identified in 2021 inBritish Columbia,Canada.[3]
![]() | Thisdrug article relating to thenervous system is astub. You can help Wikipedia byexpanding it. |